Norman Fixel Institute for Neurological Diseases
The Norman Fixel Institute for Neurological Diseases is a University of Florida Health academic medical center providing multidisciplinary specialty care, clinical trials, and research for patients with Parkinson's, Alzheimer's, ALS, MS, Huntington's, Tourette syndrome, and other neurological diseases.
- Company typePrivate
- Founded2016
- HeadquartersGainesville, United States
- Headcount51–100
- GTM typeB2C
- OfferingServices
What Norman Fixel Institute for Neurological Diseases does
The Norman Fixel Institute for Neurological Diseases is a multidisciplinary clinical and research center operating within the University of Florida Health system in Gainesville, Florida. Founded in 2016 through a major philanthropic gift from Kenneth and Laurie Fixel and renamed from the earlier Center for Movement Disorders & Neurorestoration, the institute specializes in treating complex neurological conditions including Parkinson's disease, dystonia, essential tremor, Tourette syndrome, Alzheimer's and other dementias, ALS, multiple sclerosis, traumatic brain injury, and Huntington's disease. It serves approximately 49,000+ patient visits annually through a portfolio of specialty clinics and houses designated Centers of Excellence for both Huntington's disease (HDSA) and Tourette syndrome (Tourette Association of America, one of 10 nationally). The institute is staffed by 65 employees including 30+ specialists in movement disorders and integrates neurologists, neurosurgeons, social workers, physical therapists, occupational therapists, speech therapists, and genetic counselors under a single roof to deliver coordinated, same-day multidisciplinary care.
The institute's core technology platform centers on team-based neurological care delivery augmented by advanced neuromodulation (Deep Brain Stimulation) and emerging AI tools including VisionMD computer-vision analysis for tracking Parkinson's motor symptoms and predictive analytics to distinguish between neurodegenerative diseases. It operates as the academic hub for $65+ million in federal research funding spanning 30+ UF and UF Health departments, runs 50+ active clinical trials (including the Enroll-HD observational platform with 30,000+ participants), and convenes two annual Think Tanks (DBS since 2012, AD+ for neurodegenerative co-pathology) that serve as convening venues for global experts. The upcoming Research & Technology Innovation Incubator (RTII), under construction as of September 2025, is designed to extend the institute's research footprint by enabling interdisciplinary collaboration across six UF colleges.
Revenue is generated through two primary streams: clinical care services billed to insurance, Medicare, Medicaid, and patient payments across its specialty clinics, and federal research funding (NIH grants, clinical trial sponsorships, foundation support) supplemented by philanthropy such as the $1 million Tyler's Hope gift that seeded the dystonia program. As a state-university entity rather than a venture-backed company, the institute does not publish standalone financials; its go-to-market motion is referral-driven, supported by UF Health's regional brand, the Centers of Excellence designations, the Southeast Consortium for Tourette care, and telehealth options for returning patients.
Norman Fixel Institute for Neurological Diseases firmographics
Firmographics- Name
- Norman Fixel Institute for Neurological Diseases
- Legal name
- Norman Fixel Institute for Neurological Diseases
- Website
- https://fixel.ufhealth.org
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- The Norman Fixel Institute for Neurological Diseases is a University of Florida Health academic medical center providing multidisciplinary specialty care, clinical trials, and research for patients with Parkinson's, Alzheimer's, ALS, MS, Huntington's, Tourette syndrome, and other neurological diseases.
- Ownership category
- akta.pro rank
Norman Fixel Institute for Neurological Diseases industry classification
Industry- Product category
- Specialty Neurological Care Services
- NAICS
- Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134), Services for the Elderly and Persons with Disabilities (624120)
- SIC
- Services-Health Services (8000)
- akta.pro industry
- Neurologic Rehabilitation Centers (Stroke/TBI/SCI/MS/Parkinson’s)Healthcare & Life Sciences/Elder Care & Long-Term Care/Rehabilitation & Post-Acute Care Centers (Inpatient/Outpatient)Neurologic Rehabilitation (Stroke, TBI, Parkinson’s, MS)Home & Personal Services/Fitness, Wellness & Personal Training/Physical Therapy, Rehabilitation & Corrective ExerciseDementia Care Coordination & Care Planning
Keywords
Where Norman Fixel Institute for Neurological Diseases is headquartered
LocationHeadquarters
- HQ city
- Gainesville
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Norman Fixel Institute for Neurological Diseases business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Clinical Care Services: Revenue generated from patient care services including outpatient visits, diagnostic procedures, infusion therapies, rehabilitation services, and surgical interventions. Billed through insurance, Medicare, Medicaid, and patient payments.
- Federal Research Funding: $65+ million in total federal research funding supporting programs across 30+ departments at UF and UF Health. Includes NIH grants, clinical trial sponsorships, and foundation support.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
Norman Fixel Institute for Neurological Diseases product offering
Product offeringCore offering
The Fixel Institute provides multidisciplinary neurological clinical care for movement disorders, Alzheimer's and dementia, ALS and neuromuscular disorders, traumatic brain injury, and multiple sclerosis, integrating neurologists, neurosurgeons, physical, occupational, speech, and social-work specialists under one roof. It also delivers federally funded research, clinical trials, genetic counseling, support groups, and educational training programs in neurological disease.
Product overview
The Norman Fixel Institute for Neurological Diseases is a comprehensive neurological care and research center offering a unified multidisciplinary approach to treating movement disorders, cognitive disorders, and neurodegenerative diseases. The institute operates multiple specialized clinics including Parkinson's/Dystonia/Movement Disorders Clinic, Alzheimer's/Dementia/Memory Disorder Clinic, ALS/Neuromuscular Disorder Clinic, Traumatic Brain Injury Clinic, and MS/Neuroimmunology Disorders Clinic. It also houses two designated Centers of Excellence (HDSA Huntington's Disease Center and Tourette Association of America Center of Excellence), research-focused Think Tanks (DBS Think Tank and AD+ Think Tank), and provides support services including genetic counseling, clinical trials, rehabilitation therapy, and various support groups/exercise programs. The institute's care model emphasizes collaborative treatment under one roof, integrating neurologists, neurosurgeons, social workers, physical therapists, occupational therapists, and speech therapists.
Differentiator
Problem solved
Functional benefit
Products and services
- Parkinson's, Dystonia & Movement Disorders Clinic
Quantifiable outcome
- 49,000+ annual patient visits for neurological conditions
- +2 more outcomes
Companies that use Norman Fixel Institute for Neurological Diseases
Customer profileNamed customers2 records
Segments6 records
Ideal customer profiles3 records
Norman Fixel Institute for Neurological Diseases technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature4 records
Norman Fixel Institute for Neurological Diseases partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core.
- Roche-GenentechcoreSponsor of the GENERATION HD2 clinical trial studying investigational drug Tominersen designed to target the Huntingtin protein. The Fixel Institute serves as a participating site for this pivotal trial.
- Huntington's Disease Society of America (HDSA)coreHDSA Center of Excellence designation providing comprehensive Huntington's disease care including genetic testing, clinical care, support groups, educational events, and access to HDSA resources. The institute's Huntington's disease clinic received renewal as a Center of Excellence, integrating HDSA programs and services into patient care.
- Tourette Association of AmericacoreSoutheast Consortium Center of Excellence for Tourette syndrome, one of 10 nationally designated centers. The institute coordinates regional efforts across Emory University, Medical University of South Carolina, University of Alabama at Birmingham, and University of South Florida as part of the consortium.
- Southeast Consortium (Tourette)coreCollaborative network of five Tourette Centers of Excellence including Emory University, Medical University of South Carolina, University of Alabama at Birmingham, and University of South Florida, coordinating patient care, education, and research regionally.
- Tyler Tyler’s Hope for a Dystonia CurecorePremier annual fundraiser (The Hope Weekend) celebrating 20 years of progress for DYT1 dystonia. Tyler Tyler’s Hope has contributed $1 million to establish the dystonia research center and continues to fund clinical trials and expand the Center of Excellence network.
Scale indicators5 records
Recent moves8 records
Expansion highlights5 records
Norman Fixel Institute for Neurological Diseases competitors and assessment
Company assessmentDirect peers
- Barrow Neurological Institute: Barrow is one of the few U.S. institutes dedicated exclusively to neurological care, with strong movement disorders, TBI, and DBS programs. Closest pure-play specialty-institute analog to Fixel's integrated care model.
- Shirley Ryan AbilityLab: Shirley Ryan AbilityLab is a leading U.S. neurorehabilitation and research hospital with strong TBI, MS, and Parkinson's rehab programs. Comparable to Fixel's in-house PT/OT/Speech model and research-driven rehab approach.
- Mayo Clinic Department of Neurology: Mayo Clinic operates one of the largest U.S. neurology and movement disorder programs with deep subspecialty expertise and a comparable multidisciplinary model. It is a primary competitor for complex neurological referrals and federally funded research.
- Massachusetts General Hospital Movement Disorders Unit: Mass General's neurology department runs a flagship movement disorders program integrated with research and rehabilitation services, comparable in academic structure and clinical trial participation to Fixel.
- Johns Hopkins Parkinson's Disease and Movement Disorders Center: Johns Hopkins runs one of the most prominent U.S. movement disorder centers with deep DBS expertise and major NIH-funded research. Comparable academic-based multidisciplinary model with similar Centers of Excellence recognition.
- Emory University Movement Disorders Program: Emory is a Southeast Consortium partner for the Tourette Association Center of Excellence, making it a directly cooperating and competing academic neurology program in the same regional network.
- Cleveland Clinic Neurological Institute: Cleveland Clinic's Neurological Institute houses large movement disorders, ALS, MS, and memory care programs within a single integrated specialty institute model similar to Fixel. Direct competitor for complex neurological referrals and clinical trial enrollment.
- UCSF Memory and Aging Center: UCSF Memory and Aging Center is a leading Alzheimer's and neurodegeneration specialty program with strong clinical trial infrastructure and research output. Comparable to Fixel's Alzheimer's/Dementia clinic and AD+ Think Tank mission.
Broad incumbents
- Vanderbilt University Medical Center Department of Neurology: Vanderbilt operates a broad academic neurology and neurosurgery program with overlapping subspecialties including movement disorders and dementia. Comparable in academic structure and Southeastern footprint.
- Duke University Health System Neurology: Duke's neurology and neurosurgery programs compete with Fixel for Southeast regional referrals and federal research funding, with comparable Centers of Excellence designations and clinical trial participation.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Norman Fixel Institute for Neurological Diseases social profiles
Digital presenceNorman Fixel Institute for Neurological Diseases compliance and trust
Trust signalCompliance2 records
Norman Fixel Institute for Neurological Diseases financial estimates
Financial estimateRevenue estimate
Valuation estimate
Norman Fixel Institute for Neurological Diseases leadership team
Management profileNumber of profiles
Profiles8 records
Norman Fixel Institute for Neurological Diseases funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Norman Fixel Institute for Neurological Diseases M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Norman Fixel Institute for Neurological Diseases
What does Norman Fixel Institute for Neurological Diseases do?
The Fixel Institute provides multidisciplinary neurological clinical care for movement disorders, Alzheimer's and dementia, ALS and neuromuscular disorders, traumatic brain injury, and multiple sclerosis, integrating neurologists, neurosurgeons, physical, occupational, speech, and social-work specialists under one roof. It also delivers federally funded research, clinical trials, genetic counseling, support groups, and educational training programs in neurological disease.
Is Norman Fixel Institute for Neurological Diseases a public or private company?
Norman Fixel Institute for Neurological Diseases is a private company. It is classified as state government owned and is currently operating.
When was Norman Fixel Institute for Neurological Diseases founded?
Norman Fixel Institute for Neurological Diseases was founded in 2016. It employs 51 to 100 people.
Where is Norman Fixel Institute for Neurological Diseases based?
Norman Fixel Institute for Neurological Diseases is headquartered in Gainesville, United States, in the North America region.
How does Norman Fixel Institute for Neurological Diseases make money?
Two revenue lines are on record. Clinical Care Services are the primary driver. The others are federal Research Funding.
Who are Norman Fixel Institute for Neurological Diseases's main competitors?
Direct peers on record are Barrow Neurological Institute, Shirley Ryan AbilityLab, Mayo Clinic Department of Neurology, Massachusetts General Hospital Movement Disorders Unit, Johns Hopkins Parkinson's Disease and Movement Disorders Center, Emory University Movement Disorders Program, Cleveland Clinic Neurological Institute and UCSF Memory and Aging Center. Broad incumbents are Vanderbilt University Medical Center Department of Neurology and Duke University Health System Neurology.
Does Norman Fixel Institute for Neurological Diseases have an API?
No public API is recorded for Norman Fixel Institute for Neurological Diseases.
What industry is Norman Fixel Institute for Neurological Diseases in?
Norman Fixel Institute for Neurological Diseases's product category is Specialty Neurological Care Services. Its primary akta.pro industry code is HLADAJAH, Neurologic Rehabilitation Centers (Stroke/TBI/SCI/MS/Parkinson’s), with a secondary code of HSADAIAC, Neurologic Rehabilitation (Stroke, TBI, Parkinson’s, MS). Its NAICS code is 62134 and its SIC code is 8000.